miércoles, 7 de septiembre de 2016

HHS accelerates development of mRNA-based Zika vaccine

Dept. of Health & Human Services

HHS accelerates development of mRNA-based Zika vaccine

September 7, 2016
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced an $8.2 million contract award to Moderna Therapeutics of Cambridge, Massachusetts, to help speed the development of a novel vaccine to prevent the spread of the Zika virus. 

No hay comentarios:

Publicar un comentario